QualiCell® Human Adult Ventricular Cardiac Stem Cells -XLC452

  • Specification
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C00305
Description
Human Adult Ventricular Stem Cell (Plated cells are also available). 120 Population doublings or up to 12 passages. One million viable cells upon thawing of frozen cells, frozen vial of cells shipped in dry-ice. Source: Human Adult Ventricular Cardiac tissue. Positive Markers: Troponin, alpha-actin, MEF 2C transcription factor, Sca-1+, c-kit+, LIM+ & CD34+, KDR, Nkx2.5 For non-academic use, please inquire for pricing. Cells are only guaranteed with purchase of Creative Bioarray Media, Extra Cellular Matrix, Trypsin EDTA, 1X PBS, and freezing media for the appropriate cell culture, for 30 days from the date of shipment.
Species
Human
Storage and Shipping
Liquid nitrogen. Dry ice.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Intracellular MMP9 mediates epigenetic modifications and autophagy to regulate differentiation in human cardiac stem cells

Stem Cells | DOI | Paper |

Background

Epigenetic reprogramming and autophagy are critical for stem cell differentiation, but how they are mediated in human cardiac stem cells (hCSCs) remains unclear. This study investigated intracellular matrix metalloproteinase-9 (MMP9) in hCSCs using CRISPR/Cas9-mediated MMP9 knockout, 5-azacytidine, and bafilomycin A1. Loss of MMP9 compromised DNA methylation, histone deacetylation, and histone methylation, reduced autophagosome formation via mTOR/Beclin1, and impaired cardiac lineage differentiation. Paracrine MMP9 restored epigenetic modifiers but further reduced autophagy, indicating differential endocrine/paracrine roles in hCSCs.

Key Findings

MMP9 knockout hCSCs showed decreased DNMT1, DNMT3a, SIRT1, HDAC1, H3K9me1, and H3K9me2, indicating compromised epigenetic modifications. 5-azacytidine reduced DNMT3a, H3K9me1, H3K9me2, LC3BII, and p62, linking DNA methylation inhibition to suppressed autophagy. MMP9-deficient hCSCs exhibited lower LC3BII and p62, reduced Beclin1, increased phospho-mTOR, and no change in autophagic flux after bafilomycin A1, suggesting impaired autophagosome formation rather than flux. Paracrine MMP9 supplementation restored DNMT3a, H3K9me1, H3K9me2, and HDAC1, but not SIRT1, and further decreased LC3BII while restoring p62. Cardiac lineage markers cTnT, MEF2C, and NKX2.5 were downregulated in MMP9KO hCSCs. Thus, intracellular MMP9 mediates epigenetic modifications and autophagy to promote hCSC differentiation; endocrine and paracrine MMP9 have divergent effects on autophagy.

Contribution

Creative Bioarray provided human adult ventricular cardiac stem cells (CSC-00305) and their dedicated culture medium (CM 1330Z), which supplied critical cellular materials and culture support for the establishment of the hCSC model, CRISPR/Cas9-mediated MMP9 knockout, and subsequent analyses of epigenetic modifications, autophagy, and differentiation in this study.

Schematic presentation of overall results showing that loss of intracellular MMP9 compromise epigenetic modifications that in turn reduces autophagy resulting in impaired differentiation of hCSCs.
Fig. 1. Schematic presentation of overall results showing that loss of intracellular MMP9 compromise epigenetic modifications that in turn reduces autophagy resulting in impaired differentiation of hCSCs.

MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro

Cell Death & Disease | DOI | Paper |

Background

Hyperglycemia impairs cardiac regeneration by promoting stem cell death in diabetic hearts. This study investigated whether MMP9 mediates high glucose-induced death of human cardiac stem cells (hCSCs). Using CRISPR-Cas9 to generate MMP9-/- hCSCs, the authors found that hyperglycemia increases oxidative stress and induces both apoptosis and pyroptosis. MMP9 ablation prevented these effects, improving cell viability. The findings reveal a novel intracellular role of MMP9 in stem cell death and suggest that MMP9 inhibition could enhance hCSC survival in regenerative therapy for diabetic hearts.

Key Findings

Hyperglycemia upregulated MMP9 activity and increased hCSC death via apoptosis and pyroptosis. In MMP9-/- hCSCs, high glucose failed to induce caspase-3 activation, PARP cleavage, BAD upregulation, and cytochrome c release, indicating blocked apoptosis. Similarly, pyroptosis markers NLRP3, ASC, caspase-1, GSDMD, and IL-1β were not upregulated in MMP9-/- cells. MMP9 deletion also prevented hyperglycemia-induced ROS production and SAPK/JNK activation, and improved cell viability. Under H2O2-induced oxidative stress, MMP9-/- hCSCs showed reduced apoptosis and pyroptosis. These results demonstrate that MMP9 mediates hyperglycemia-induced hCSC death through the ROS-JNK pathway, and its absence enhances stem cell survival.

Contribution

Creative Bioarray provided human adult ventricular cardiac stem cells (hCSCs) and the corresponding culture medium (CM 1330Z). These cells expressed Sca1+, MEF2C, and Nkx2.5, and lacked β-MHC, confirming their undifferentiated state. They were essential for generating MMP9-/- hCSCs and investigating hyperglycemia-induced cell death mechanisms.

Ablation of MMP9 prevents hyperglycemia-induced pyroptosis in hCSCs.
Fig. 2. Ablation of MMP9 prevents hyperglycemia-induced pyroptosis in hCSCs.

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products